Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma

Jessica E. Maxwell, Maria K. Gule-Monroe, Vivek Subbiah, Mimi Hu, Nancy D. Perrier, Maria E. Cabanillas, Jeffery E. Lee, Paul H. Graham, Gilbert J. Cote, Naifa L. Busaidy, Elizabeth G. Grubbs

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences